✦ LIBER ✦

Drug resistance: Still a daunting challenge to the successful treatment of AML

✍ Scribed by Shaffer, Brian C. (author);Gillet, Jean Pierre (author);Patel, Chirayu (author);Baer, Maria R. (author);Bates, Susan E. (author);Gottesman, Michael M. (author)

Book ID: 116413350
Publisher: Churchill Livingstone
Year: 2012
Tongue: English
Weight: 349 KB
Volume: 15
Category: Article
ISSN: 1368-7646
DOI: 10.1016/j.drup.2012.02.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drug resistance: Still a daunting challe

Drug resistance: Still a daunting challenge to the successful treatment of AML

✍ Shaffer, Brian C. (author);Gillet, Jean Pierre (author);Patel, Chirayu (author); 📂 Article 📅 2012 🏛 Churchill Livingstone 🌐 English ⚖ 349 KB

Successful treatment of congenital pseud

Successful treatment of congenital pseudarthrosis of the tibia: still a challenge

✍ K. Bobotas, S. N. Lallos, V. S. Nikolaou… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 597 KB

Resistance to adefovir: A new challenge

Resistance to adefovir: A new challenge in the treatment of chronic hepatitis B

✍ Patrick Marcellin; Tarik Asselah 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Editorial: The treatment of multi-drug r

Editorial: The treatment of multi-drug resistant tuberculosis – a return to the pre-antibiotic era?

✍ Jaime E. Ollé-Goig 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 57 KB

Corrigendum to “Resistance to adefovir:

Corrigendum to “Resistance to adefovir: A new challenge in the treatment of chronic hepatitis B” [J Hepatol 43 (2005) 920–923]

✍ Patrick Marcellin; Tarik Asselah 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Botulinum toxin-type A in the treatment

Botulinum toxin-type A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury

✍ PRASAD S. PATKI; RIZWAN HAMID; KIRUPAKAR ARUMUGAM; P. JULIAN R. SHAH; MIKE CRAGG 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB